Clinical trials in Shelby, NC

12 recruiting studies have a site in or near Shelby, NC, North Carolina.

Top conditions here

All conditions

Showing 12 of 12 studies

RecruitingPhase 3NCT05980949

Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)

Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company

Greensboro, NC · Matthews, NC · Morehead City, NC · +145 more sites

RecruitingPhase 3NCT07674654

A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine

Sponsor: Kallyope Inc.

Charlotte, NC · Greensboro, NC · +110 more sites

RecruitingPhase 2NCT06897475

A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide

Sponsor: Eli Lilly and Company

Morehead City, NC · Shelby, NC · +23 more sites

RecruitingPhase 3NCT06961214

Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)

Sponsor: GlaxoSmithKline

Shelby, NC · +56 more sites

RecruitingPhase 3NCT07684235

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

Sponsor: Amgen

Hickory, NC · Shelby, NC · +69 more sites

RecruitingPhase 2NCT07684820

To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment

Sponsor: Expedition Therapeutics, Inc

Shelby, NC · +21 more sites

RecruitingPhase 3NCT06585787

A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)

Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company

Greensboro, NC · Matthews, NC · Morehead City, NC · +99 more sites

RecruitingPhase 3NCT05879926

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Sponsor: NRG Oncology

Albemarle, NC · Asheboro, NC · +1223 more sites

RecruitingPhase 3NCT07645924

A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine

Sponsor: Kallyope Inc.

Charlotte, NC · Greensboro, NC · +110 more sites

RecruitingPhase 3NCT05812807

Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab

Sponsor: Alliance for Clinical Trials in Oncology

Albemarle, NC · Asheboro, NC · +825 more sites

RecruitingPhase 3NCT06748222

E-Mindfulness Approaches for Living After Breast Cancer

Sponsor: NRG Oncology

Albemarle, NC · Asheboro, NC · Burlington, NC · +378 more sites

RecruitingPhase 3NCT04852887

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

Sponsor: NRG Oncology

Albemarle, NC · Asheville, NC · +809 more sites

Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.